Skip to search formSkip to main contentSkip to account menu

MDL-17,043

Known as: MDL 17043, MDL-17043, MDL17043 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Enoximone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
MDL-17,043 (Piroximone)
MDL-17,043, a new drug combining positive inotropic and peripheral vasodilatory properties, was found to be effective in… 
Highly Cited
1985
Highly Cited
1985
Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.
Thirteen male patients with NYHA class IV congestive heart failure refractory to conventional therapy were treated with oral… 
1985
1985
MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
1985
1985
Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failure.
1985
1985
Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
1984
1984
Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
1984
1984
Simultaneous analysis of a new cardiotonic agent, MDL 17,043, and its major sulfoxide metabolite in plasma by high-performance liquid chromatography.
1983
1983
Effect of MDL 17043, a new cardiotonic agent, on myocardial oxygen consumption
this way the amount of insulin adhering to the membrane after washing could be determined. Fig. 1 shows the effect of three of… 
Highly Cited
1982
Highly Cited
1982
Cardiovascular Properties of a New Cardiotonic Agent: MDL 17,043 (1,3‐Dihydro-4‐methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol‐2-one)
The cardiovascular properties of a new noncatechol, nonglycoside cardiotonic agent, MDL 17.043, were investigated in anesthetized… 
Highly Cited
1982
Highly Cited
1982
Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3‐Dihydro-4‐methyl-5-[4-(methylthio)-benzoyl]-2H‐imidazol-2‐one)
Summary The cardiovascular actions of 1,3-dihydro-4-methyl-5[4-(methylthio)-benzoyl]-2H-imidazol-2-one (MDL 17043), a new non… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)